nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—epilepsy syndrome	0.112	0.311	CbGaD
Acamprosate—GRM5—Rufinamide—epilepsy syndrome	0.0959	0.243	CbGbCtD
Acamprosate—SLC36A1—Vigabatrin—epilepsy syndrome	0.0758	0.192	CbGbCtD
Acamprosate—GRIN2A—epilepsy syndrome	0.0613	0.171	CbGaD
Acamprosate—GABRG2—epilepsy syndrome	0.0538	0.15	CbGaD
Acamprosate—GRIN2B—epilepsy syndrome	0.0522	0.145	CbGaD
Acamprosate—GABRB3—epilepsy syndrome	0.0433	0.12	CbGaD
Acamprosate—GRIN2A—Felbamate—epilepsy syndrome	0.0415	0.105	CbGbCtD
Acamprosate—GRIN2B—Felbamate—epilepsy syndrome	0.0415	0.105	CbGbCtD
Acamprosate—GABRA1—epilepsy syndrome	0.0372	0.103	CbGaD
Acamprosate—GRIN3A—Felbamate—epilepsy syndrome	0.0276	0.0698	CbGbCtD
Acamprosate—GABRG2—Clonazepam—epilepsy syndrome	0.00896	0.0227	CbGbCtD
Acamprosate—GABRG2—Clobazam—epilepsy syndrome	0.00859	0.0217	CbGbCtD
Acamprosate—GABRA1—Clonazepam—epilepsy syndrome	0.00745	0.0188	CbGbCtD
Acamprosate—GABRA1—Clobazam—epilepsy syndrome	0.00714	0.0181	CbGbCtD
Acamprosate—GABRB3—Propofol—epilepsy syndrome	0.00672	0.017	CbGbCtD
Acamprosate—GABRG2—Primidone—epilepsy syndrome	0.00664	0.0168	CbGbCtD
Acamprosate—GABRA1—Amobarbital—epilepsy syndrome	0.00664	0.0168	CbGbCtD
Acamprosate—GABRB3—Midazolam—epilepsy syndrome	0.00633	0.016	CbGbCtD
Acamprosate—GABRB3—Diazepam—epilepsy syndrome	0.00608	0.0154	CbGbCtD
Acamprosate—GABRG2—Propofol—epilepsy syndrome	0.00595	0.0151	CbGbCtD
Acamprosate—GABRG2—Midazolam—epilepsy syndrome	0.00561	0.0142	CbGbCtD
Acamprosate—GABRA1—Primidone—epilepsy syndrome	0.00552	0.014	CbGbCtD
Acamprosate—GABRG2—Diazepam—epilepsy syndrome	0.00539	0.0136	CbGbCtD
Acamprosate—GABRA1—Propofol—epilepsy syndrome	0.00495	0.0125	CbGbCtD
Acamprosate—GABRA1—Phenobarbital—epilepsy syndrome	0.00473	0.012	CbGbCtD
Acamprosate—GABRA1—Midazolam—epilepsy syndrome	0.00466	0.0118	CbGbCtD
Acamprosate—GABRA1—Diazepam—epilepsy syndrome	0.00448	0.0113	CbGbCtD
Acamprosate—GABRG2—Topiramate—epilepsy syndrome	0.00384	0.0097	CbGbCtD
Acamprosate—GABRA1—Topiramate—epilepsy syndrome	0.00319	0.00807	CbGbCtD
Acamprosate—GRM5—telencephalic ventricle—epilepsy syndrome	0.00279	0.0601	CbGeAlD
Acamprosate—GRIN1—telencephalic ventricle—epilepsy syndrome	0.00176	0.0379	CbGeAlD
Acamprosate—GRM5—ganglion—epilepsy syndrome	0.00174	0.0374	CbGeAlD
Acamprosate—GRIN2B—telencephalic ventricle—epilepsy syndrome	0.00168	0.0362	CbGeAlD
Acamprosate—GRM5—hindbrain—epilepsy syndrome	0.00132	0.0284	CbGeAlD
Acamprosate—GRIN1—ganglion—epilepsy syndrome	0.0011	0.0236	CbGeAlD
Acamprosate—GRIN2B—ganglion—epilepsy syndrome	0.00105	0.0225	CbGeAlD
Acamprosate—GRIN2C—hindbrain—epilepsy syndrome	0.001	0.0216	CbGeAlD
Acamprosate—GRIN2D—hindbrain—epilepsy syndrome	0.000934	0.0201	CbGeAlD
Acamprosate—GRIN2A—ganglion—epilepsy syndrome	0.000915	0.0197	CbGeAlD
Acamprosate—GRIN1—hindbrain—epilepsy syndrome	0.000832	0.0179	CbGeAlD
Acamprosate—GRIN2B—hindbrain—epilepsy syndrome	0.000794	0.0171	CbGeAlD
Acamprosate—GRM5—brainstem—epilepsy syndrome	0.000756	0.0163	CbGeAlD
Acamprosate—GRM5—forebrain—epilepsy syndrome	0.000729	0.0157	CbGeAlD
Acamprosate—GRIN2A—hindbrain—epilepsy syndrome	0.000694	0.0149	CbGeAlD
Acamprosate—SLC36A1—hindbrain—epilepsy syndrome	0.00069	0.0148	CbGeAlD
Acamprosate—GRM5—telencephalon—epilepsy syndrome	0.000671	0.0144	CbGeAlD
Acamprosate—GRIN2C—brainstem—epilepsy syndrome	0.000576	0.0124	CbGeAlD
Acamprosate—GRIN2C—forebrain—epilepsy syndrome	0.000556	0.012	CbGeAlD
Acamprosate—GRIN2D—brainstem—epilepsy syndrome	0.000535	0.0115	CbGeAlD
Acamprosate—GRIN2D—forebrain—epilepsy syndrome	0.000517	0.0111	CbGeAlD
Acamprosate—GRIN2C—telencephalon—epilepsy syndrome	0.000511	0.011	CbGeAlD
Acamprosate—GRIN3A—forebrain—epilepsy syndrome	0.000486	0.0104	CbGeAlD
Acamprosate—GRM5—midbrain—epilepsy syndrome	0.000482	0.0104	CbGeAlD
Acamprosate—GRIN1—brainstem—epilepsy syndrome	0.000477	0.0103	CbGeAlD
Acamprosate—GRIN2D—telencephalon—epilepsy syndrome	0.000475	0.0102	CbGeAlD
Acamprosate—GRM5—spinal cord—epilepsy syndrome	0.00047	0.0101	CbGeAlD
Acamprosate—GRIN1—forebrain—epilepsy syndrome	0.00046	0.00991	CbGeAlD
Acamprosate—GRIN2B—brainstem—epilepsy syndrome	0.000455	0.00979	CbGeAlD
Acamprosate—GRIN3A—telencephalon—epilepsy syndrome	0.000447	0.00961	CbGeAlD
Acamprosate—GRIN2B—forebrain—epilepsy syndrome	0.000439	0.00945	CbGeAlD
Acamprosate—GRIN1—telencephalon—epilepsy syndrome	0.000423	0.00911	CbGeAlD
Acamprosate—GRM5—head—epilepsy syndrome	0.000418	0.00898	CbGeAlD
Acamprosate—GRIN2B—telencephalon—epilepsy syndrome	0.000404	0.00869	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—epilepsy syndrome	0.000401	0.00864	CbGeAlD
Acamprosate—GRIN2A—brainstem—epilepsy syndrome	0.000398	0.00856	CbGeAlD
Acamprosate—GRM5—nervous system—epilepsy syndrome	0.000396	0.00852	CbGeAlD
Acamprosate—SLC36A1—brainstem—epilepsy syndrome	0.000395	0.0085	CbGeAlD
Acamprosate—GABRA1—hindbrain—epilepsy syndrome	0.000386	0.00831	CbGeAlD
Acamprosate—GRIN2A—forebrain—epilepsy syndrome	0.000384	0.00826	CbGeAlD
Acamprosate—GRM5—central nervous system—epilepsy syndrome	0.000381	0.0082	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—epilepsy syndrome	0.000373	0.00803	CbGeAlD
Acamprosate—GRM5—cerebellum—epilepsy syndrome	0.000373	0.00802	CbGeAlD
Acamprosate—GRIN2A—telencephalon—epilepsy syndrome	0.000353	0.00759	CbGeAlD
Acamprosate—SLC36A1—telencephalon—epilepsy syndrome	0.000351	0.00755	CbGeAlD
Acamprosate—GRIN2D—spinal cord—epilepsy syndrome	0.000333	0.00716	CbGeAlD
Acamprosate—GRIN2C—head—epilepsy syndrome	0.000318	0.00684	CbGeAlD
Acamprosate—GRIN1—midbrain—epilepsy syndrome	0.000304	0.00654	CbGeAlD
Acamprosate—GRM5—brain—epilepsy syndrome	0.000303	0.00651	CbGeAlD
Acamprosate—GRIN2C—nervous system—epilepsy syndrome	0.000302	0.00649	CbGeAlD
Acamprosate—GRIN1—spinal cord—epilepsy syndrome	0.000297	0.00638	CbGeAlD
Acamprosate—GRIN2D—head—epilepsy syndrome	0.000296	0.00636	CbGeAlD
Acamprosate—GRIN2C—central nervous system—epilepsy syndrome	0.00029	0.00625	CbGeAlD
Acamprosate—GRIN2C—cerebellum—epilepsy syndrome	0.000284	0.00611	CbGeAlD
Acamprosate—GRIN2B—spinal cord—epilepsy syndrome	0.000283	0.00609	CbGeAlD
Acamprosate—GRIN2D—nervous system—epilepsy syndrome	0.00028	0.00603	CbGeAlD
Acamprosate—GRIN3A—head—epilepsy syndrome	0.000278	0.00598	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—epilepsy syndrome	0.000277	0.00597	CbGeAlD
Acamprosate—GRIN2D—central nervous system—epilepsy syndrome	0.00027	0.00581	CbGeAlD
Acamprosate—GRIN2D—cerebellum—epilepsy syndrome	0.000264	0.00568	CbGeAlD
Acamprosate—GRIN3A—nervous system—epilepsy syndrome	0.000264	0.00567	CbGeAlD
Acamprosate—GRIN1—head—epilepsy syndrome	0.000264	0.00567	CbGeAlD
Acamprosate—GRIN3A—central nervous system—epilepsy syndrome	0.000254	0.00546	CbGeAlD
Acamprosate—GRIN2A—midbrain—epilepsy syndrome	0.000254	0.00545	CbGeAlD
Acamprosate—GRIN2B—head—epilepsy syndrome	0.000252	0.00541	CbGeAlD
Acamprosate—GRIN1—nervous system—epilepsy syndrome	0.00025	0.00538	CbGeAlD
Acamprosate—GRIN2A—spinal cord—epilepsy syndrome	0.000247	0.00532	CbGeAlD
Acamprosate—GABRG2—forebrain—epilepsy syndrome	0.000242	0.0052	CbGeAlD
Acamprosate—GRIN1—central nervous system—epilepsy syndrome	0.000241	0.00518	CbGeAlD
Acamprosate—GRIN2B—nervous system—epilepsy syndrome	0.000238	0.00513	CbGeAlD
Acamprosate—GRIN1—cerebellum—epilepsy syndrome	0.000235	0.00506	CbGeAlD
Acamprosate—GRIN2C—brain—epilepsy syndrome	0.000231	0.00496	CbGeAlD
Acamprosate—GRIN2B—central nervous system—epilepsy syndrome	0.00023	0.00494	CbGeAlD
Acamprosate—GRIN2B—cerebellum—epilepsy syndrome	0.000224	0.00483	CbGeAlD
Acamprosate—GABRG2—telencephalon—epilepsy syndrome	0.000222	0.00478	CbGeAlD
Acamprosate—GABRA1—brainstem—epilepsy syndrome	0.000221	0.00476	CbGeAlD
Acamprosate—GRIN2A—head—epilepsy syndrome	0.00022	0.00473	CbGeAlD
Acamprosate—SLC36A1—head—epilepsy syndrome	0.000218	0.0047	CbGeAlD
Acamprosate—GRIN2D—brain—epilepsy syndrome	0.000214	0.00461	CbGeAlD
Acamprosate—GABRA1—forebrain—epilepsy syndrome	0.000214	0.00459	CbGeAlD
Acamprosate—GRIN2A—nervous system—epilepsy syndrome	0.000208	0.00448	CbGeAlD
Acamprosate—SLC36A1—nervous system—epilepsy syndrome	0.000207	0.00446	CbGeAlD
Acamprosate—GRIN3A—brain—epilepsy syndrome	0.000202	0.00434	CbGeAlD
Acamprosate—GRIN2A—central nervous system—epilepsy syndrome	0.000201	0.00432	CbGeAlD
Acamprosate—SLC36A1—central nervous system—epilepsy syndrome	0.000199	0.00429	CbGeAlD
Acamprosate—GABRA1—telencephalon—epilepsy syndrome	0.000196	0.00422	CbGeAlD
Acamprosate—GRIN2A—cerebellum—epilepsy syndrome	0.000196	0.00422	CbGeAlD
Acamprosate—SLC36A1—cerebellum—epilepsy syndrome	0.000195	0.00419	CbGeAlD
Acamprosate—GRIN1—brain—epilepsy syndrome	0.000191	0.00411	CbGeAlD
Acamprosate—GABRB3—forebrain—epilepsy syndrome	0.000186	0.004	CbGeAlD
Acamprosate—GRIN2B—brain—epilepsy syndrome	0.000182	0.00392	CbGeAlD
Acamprosate—GABRG2—medulla oblongata—epilepsy syndrome	0.000175	0.00376	CbGeAlD
Acamprosate—GABRB3—telencephalon—epilepsy syndrome	0.000171	0.00367	CbGeAlD
Acamprosate—GABRG2—midbrain—epilepsy syndrome	0.00016	0.00344	CbGeAlD
Acamprosate—GRIN2A—brain—epilepsy syndrome	0.000159	0.00343	CbGeAlD
Acamprosate—SLC36A1—brain—epilepsy syndrome	0.000158	0.00341	CbGeAlD
Acamprosate—GABRG2—spinal cord—epilepsy syndrome	0.000156	0.00335	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—epilepsy syndrome	0.000154	0.00332	CbGeAlD
Acamprosate—GABRA1—midbrain—epilepsy syndrome	0.000141	0.00303	CbGeAlD
Acamprosate—GABRG2—head—epilepsy syndrome	0.000138	0.00298	CbGeAlD
Acamprosate—GABRA1—spinal cord—epilepsy syndrome	0.000138	0.00296	CbGeAlD
Acamprosate—GABRB3—medulla oblongata—epilepsy syndrome	0.000134	0.00289	CbGeAlD
Acamprosate—GABRG2—nervous system—epilepsy syndrome	0.000131	0.00282	CbGeAlD
Acamprosate—GABRG2—central nervous system—epilepsy syndrome	0.000126	0.00272	CbGeAlD
Acamprosate—GABRG2—cerebellum—epilepsy syndrome	0.000124	0.00266	CbGeAlD
Acamprosate—GABRB3—midbrain—epilepsy syndrome	0.000123	0.00264	CbGeAlD
Acamprosate—GABRA1—head—epilepsy syndrome	0.000122	0.00263	CbGeAlD
Acamprosate—GABRB3—spinal cord—epilepsy syndrome	0.00012	0.00257	CbGeAlD
Acamprosate—GABRA1—nervous system—epilepsy syndrome	0.000116	0.00249	CbGeAlD
Acamprosate—GABRA1—central nervous system—epilepsy syndrome	0.000112	0.0024	CbGeAlD
Acamprosate—GABRA1—cerebellum—epilepsy syndrome	0.000109	0.00235	CbGeAlD
Acamprosate—GABRB3—head—epilepsy syndrome	0.000106	0.00229	CbGeAlD
Acamprosate—GABRB3—nervous system—epilepsy syndrome	0.000101	0.00217	CbGeAlD
Acamprosate—GABRG2—brain—epilepsy syndrome	0.0001	0.00216	CbGeAlD
Acamprosate—GABRB3—central nervous system—epilepsy syndrome	9.71e-05	0.00209	CbGeAlD
Acamprosate—GABRB3—cerebellum—epilepsy syndrome	9.49e-05	0.00204	CbGeAlD
Acamprosate—GABRA1—brain—epilepsy syndrome	8.86e-05	0.00191	CbGeAlD
Acamprosate—GABRB3—brain—epilepsy syndrome	7.71e-05	0.00166	CbGeAlD
Acamprosate—Hypertension—Pregabalin—epilepsy syndrome	1.87e-05	0.000164	CcSEcCtD
Acamprosate—Vomiting—Diazepam—epilepsy syndrome	1.87e-05	0.000164	CcSEcCtD
Acamprosate—Anorexia—Valproic Acid—epilepsy syndrome	1.87e-05	0.000164	CcSEcCtD
Acamprosate—Tremor—Gabapentin—epilepsy syndrome	1.86e-05	0.000163	CcSEcCtD
Acamprosate—Rash—Diazepam—epilepsy syndrome	1.86e-05	0.000163	CcSEcCtD
Acamprosate—Dermatitis—Diazepam—epilepsy syndrome	1.86e-05	0.000163	CcSEcCtD
Acamprosate—Visual impairment—Topiramate—epilepsy syndrome	1.85e-05	0.000163	CcSEcCtD
Acamprosate—Chest pain—Pregabalin—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Arthralgia—Pregabalin—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Myalgia—Pregabalin—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Dizziness—Zonisamide—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Headache—Diazepam—epilepsy syndrome	1.85e-05	0.000162	CcSEcCtD
Acamprosate—Anxiety—Pregabalin—epilepsy syndrome	1.84e-05	0.000161	CcSEcCtD
Acamprosate—Diarrhoea—Clonazepam—epilepsy syndrome	1.84e-05	0.000161	CcSEcCtD
Acamprosate—Anaemia—Gabapentin—epilepsy syndrome	1.84e-05	0.000161	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.83e-05	0.000161	CcSEcCtD
Acamprosate—Hypotension—Valproic Acid—epilepsy syndrome	1.83e-05	0.000161	CcSEcCtD
Acamprosate—Asthenia—Carbamazepine—epilepsy syndrome	1.83e-05	0.00016	CcSEcCtD
Acamprosate—Agitation—Gabapentin—epilepsy syndrome	1.83e-05	0.00016	CcSEcCtD
Acamprosate—Diarrhoea—Phenytoin—epilepsy syndrome	1.83e-05	0.00016	CcSEcCtD
Acamprosate—Discomfort—Pregabalin—epilepsy syndrome	1.83e-05	0.00016	CcSEcCtD
Acamprosate—Nausea—Fosphenytoin—epilepsy syndrome	1.82e-05	0.00016	CcSEcCtD
Acamprosate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.82e-05	0.000159	CcSEcCtD
Acamprosate—Angioedema—Gabapentin—epilepsy syndrome	1.82e-05	0.000159	CcSEcCtD
Acamprosate—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.82e-05	0.000159	CcSEcCtD
Acamprosate—Vomiting—Felbamate—epilepsy syndrome	1.81e-05	0.000159	CcSEcCtD
Acamprosate—Dry mouth—Pregabalin—epilepsy syndrome	1.81e-05	0.000158	CcSEcCtD
Acamprosate—Pruritus—Carbamazepine—epilepsy syndrome	1.8e-05	0.000158	CcSEcCtD
Acamprosate—Rash—Felbamate—epilepsy syndrome	1.8e-05	0.000158	CcSEcCtD
Acamprosate—Dermatitis—Felbamate—epilepsy syndrome	1.8e-05	0.000158	CcSEcCtD
Acamprosate—Malaise—Gabapentin—epilepsy syndrome	1.79e-05	0.000157	CcSEcCtD
Acamprosate—Tinnitus—Topiramate—epilepsy syndrome	1.79e-05	0.000157	CcSEcCtD
Acamprosate—Vertigo—Gabapentin—epilepsy syndrome	1.79e-05	0.000157	CcSEcCtD
Acamprosate—Headache—Felbamate—epilepsy syndrome	1.79e-05	0.000157	CcSEcCtD
Acamprosate—Confusional state—Pregabalin—epilepsy syndrome	1.79e-05	0.000157	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.78e-05	0.000157	CcSEcCtD
Acamprosate—Syncope—Gabapentin—epilepsy syndrome	1.78e-05	0.000156	CcSEcCtD
Acamprosate—Leukopenia—Gabapentin—epilepsy syndrome	1.78e-05	0.000156	CcSEcCtD
Acamprosate—Dizziness—Clonazepam—epilepsy syndrome	1.78e-05	0.000156	CcSEcCtD
Acamprosate—Nausea—Vigabatrin—epilepsy syndrome	1.78e-05	0.000156	CcSEcCtD
Acamprosate—Vomiting—Zonisamide—epilepsy syndrome	1.77e-05	0.000156	CcSEcCtD
Acamprosate—Insomnia—Valproic Acid—epilepsy syndrome	1.77e-05	0.000155	CcSEcCtD
Acamprosate—Anaphylactic shock—Pregabalin—epilepsy syndrome	1.77e-05	0.000155	CcSEcCtD
Acamprosate—Asthenia—Lamotrigine—epilepsy syndrome	1.77e-05	0.000155	CcSEcCtD
Acamprosate—Dizziness—Phenytoin—epilepsy syndrome	1.77e-05	0.000155	CcSEcCtD
Acamprosate—Rash—Zonisamide—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Infection—Pregabalin—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Paraesthesia—Valproic Acid—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Palpitations—Gabapentin—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Dermatitis—Zonisamide—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Dizziness—Oxcarbazepine—epilepsy syndrome	1.76e-05	0.000154	CcSEcCtD
Acamprosate—Nausea—Diazepam—epilepsy syndrome	1.75e-05	0.000153	CcSEcCtD
Acamprosate—Loss of consciousness—Gabapentin—epilepsy syndrome	1.75e-05	0.000153	CcSEcCtD
Acamprosate—Headache—Zonisamide—epilepsy syndrome	1.75e-05	0.000153	CcSEcCtD
Acamprosate—Dyspnoea—Valproic Acid—epilepsy syndrome	1.75e-05	0.000153	CcSEcCtD
Acamprosate—Diarrhoea—Carbamazepine—epilepsy syndrome	1.75e-05	0.000153	CcSEcCtD
Acamprosate—Pruritus—Lamotrigine—epilepsy syndrome	1.74e-05	0.000153	CcSEcCtD
Acamprosate—Shock—Pregabalin—epilepsy syndrome	1.74e-05	0.000153	CcSEcCtD
Acamprosate—Somnolence—Valproic Acid—epilepsy syndrome	1.74e-05	0.000153	CcSEcCtD
Acamprosate—Immune system disorder—Topiramate—epilepsy syndrome	1.74e-05	0.000152	CcSEcCtD
Acamprosate—Cough—Gabapentin—epilepsy syndrome	1.74e-05	0.000152	CcSEcCtD
Acamprosate—Thrombocytopenia—Pregabalin—epilepsy syndrome	1.73e-05	0.000152	CcSEcCtD
Acamprosate—Tachycardia—Pregabalin—epilepsy syndrome	1.73e-05	0.000152	CcSEcCtD
Acamprosate—Chills—Topiramate—epilepsy syndrome	1.73e-05	0.000151	CcSEcCtD
Acamprosate—Dyspepsia—Valproic Acid—epilepsy syndrome	1.72e-05	0.000151	CcSEcCtD
Acamprosate—Convulsion—Gabapentin—epilepsy syndrome	1.72e-05	0.000151	CcSEcCtD
Acamprosate—Skin disorder—Pregabalin—epilepsy syndrome	1.72e-05	0.000151	CcSEcCtD
Acamprosate—Hypertension—Gabapentin—epilepsy syndrome	1.72e-05	0.000151	CcSEcCtD
Acamprosate—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.71e-05	0.00015	CcSEcCtD
Acamprosate—Vomiting—Clonazepam—epilepsy syndrome	1.71e-05	0.00015	CcSEcCtD
Acamprosate—Decreased appetite—Valproic Acid—epilepsy syndrome	1.7e-05	0.000149	CcSEcCtD
Acamprosate—Alopecia—Topiramate—epilepsy syndrome	1.7e-05	0.000149	CcSEcCtD
Acamprosate—Vomiting—Phenytoin—epilepsy syndrome	1.7e-05	0.000149	CcSEcCtD
Acamprosate—Rash—Clonazepam—epilepsy syndrome	1.7e-05	0.000149	CcSEcCtD
Acamprosate—Dermatitis—Clonazepam—epilepsy syndrome	1.69e-05	0.000149	CcSEcCtD
Acamprosate—Myalgia—Gabapentin—epilepsy syndrome	1.69e-05	0.000149	CcSEcCtD
Acamprosate—Chest pain—Gabapentin—epilepsy syndrome	1.69e-05	0.000149	CcSEcCtD
Acamprosate—Arthralgia—Gabapentin—epilepsy syndrome	1.69e-05	0.000149	CcSEcCtD
Acamprosate—Nausea—Felbamate—epilepsy syndrome	1.69e-05	0.000149	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Vomiting—Oxcarbazepine—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Anxiety—Gabapentin—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Anorexia—Pregabalin—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Dizziness—Carbamazepine—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Diarrhoea—Lamotrigine—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Headache—Clonazepam—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Rash—Phenytoin—epilepsy syndrome	1.69e-05	0.000148	CcSEcCtD
Acamprosate—Mental disorder—Topiramate—epilepsy syndrome	1.68e-05	0.000148	CcSEcCtD
Acamprosate—Dermatitis—Phenytoin—epilepsy syndrome	1.68e-05	0.000148	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.68e-05	0.000148	CcSEcCtD
Acamprosate—Rash—Oxcarbazepine—epilepsy syndrome	1.68e-05	0.000147	CcSEcCtD
Acamprosate—Pain—Valproic Acid—epilepsy syndrome	1.68e-05	0.000147	CcSEcCtD
Acamprosate—Constipation—Valproic Acid—epilepsy syndrome	1.68e-05	0.000147	CcSEcCtD
Acamprosate—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.67e-05	0.000147	CcSEcCtD
Acamprosate—Headache—Phenytoin—epilepsy syndrome	1.67e-05	0.000147	CcSEcCtD
Acamprosate—Malnutrition—Topiramate—epilepsy syndrome	1.67e-05	0.000147	CcSEcCtD
Acamprosate—Discomfort—Gabapentin—epilepsy syndrome	1.67e-05	0.000147	CcSEcCtD
Acamprosate—Headache—Oxcarbazepine—epilepsy syndrome	1.67e-05	0.000146	CcSEcCtD
Acamprosate—Nausea—Zonisamide—epilepsy syndrome	1.66e-05	0.000145	CcSEcCtD
Acamprosate—Dry mouth—Gabapentin—epilepsy syndrome	1.66e-05	0.000145	CcSEcCtD
Acamprosate—Hypotension—Pregabalin—epilepsy syndrome	1.66e-05	0.000145	CcSEcCtD
Acamprosate—Flatulence—Topiramate—epilepsy syndrome	1.65e-05	0.000145	CcSEcCtD
Acamprosate—Tension—Topiramate—epilepsy syndrome	1.64e-05	0.000144	CcSEcCtD
Acamprosate—Dysgeusia—Topiramate—epilepsy syndrome	1.64e-05	0.000144	CcSEcCtD
Acamprosate—Confusional state—Gabapentin—epilepsy syndrome	1.64e-05	0.000144	CcSEcCtD
Acamprosate—Dizziness—Lamotrigine—epilepsy syndrome	1.63e-05	0.000143	CcSEcCtD
Acamprosate—Nervousness—Topiramate—epilepsy syndrome	1.63e-05	0.000143	CcSEcCtD
Acamprosate—Anaphylactic shock—Gabapentin—epilepsy syndrome	1.62e-05	0.000142	CcSEcCtD
Acamprosate—Vomiting—Carbamazepine—epilepsy syndrome	1.62e-05	0.000142	CcSEcCtD
Acamprosate—Back pain—Topiramate—epilepsy syndrome	1.62e-05	0.000142	CcSEcCtD
Acamprosate—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.61e-05	0.000142	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.61e-05	0.000142	CcSEcCtD
Acamprosate—Infection—Gabapentin—epilepsy syndrome	1.61e-05	0.000141	CcSEcCtD
Acamprosate—Muscle spasms—Topiramate—epilepsy syndrome	1.61e-05	0.000141	CcSEcCtD
Acamprosate—Rash—Carbamazepine—epilepsy syndrome	1.61e-05	0.000141	CcSEcCtD
Acamprosate—Dermatitis—Carbamazepine—epilepsy syndrome	1.61e-05	0.000141	CcSEcCtD
Acamprosate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.6e-05	0.00014	CcSEcCtD
Acamprosate—Insomnia—Pregabalin—epilepsy syndrome	1.6e-05	0.00014	CcSEcCtD
Acamprosate—Nausea—Clonazepam—epilepsy syndrome	1.6e-05	0.00014	CcSEcCtD
Acamprosate—Headache—Carbamazepine—epilepsy syndrome	1.6e-05	0.00014	CcSEcCtD
Acamprosate—Shock—Gabapentin—epilepsy syndrome	1.6e-05	0.00014	CcSEcCtD
Acamprosate—Paraesthesia—Pregabalin—epilepsy syndrome	1.59e-05	0.000139	CcSEcCtD
Acamprosate—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.59e-05	0.000139	CcSEcCtD
Acamprosate—Nausea—Phenytoin—epilepsy syndrome	1.59e-05	0.000139	CcSEcCtD
Acamprosate—Tachycardia—Gabapentin—epilepsy syndrome	1.59e-05	0.000139	CcSEcCtD
Acamprosate—Dyspnoea—Pregabalin—epilepsy syndrome	1.58e-05	0.000138	CcSEcCtD
Acamprosate—Nausea—Oxcarbazepine—epilepsy syndrome	1.58e-05	0.000138	CcSEcCtD
Acamprosate—Skin disorder—Gabapentin—epilepsy syndrome	1.58e-05	0.000138	CcSEcCtD
Acamprosate—Somnolence—Pregabalin—epilepsy syndrome	1.57e-05	0.000138	CcSEcCtD
Acamprosate—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.57e-05	0.000138	CcSEcCtD
Acamprosate—Tremor—Topiramate—epilepsy syndrome	1.57e-05	0.000138	CcSEcCtD
Acamprosate—Vomiting—Lamotrigine—epilepsy syndrome	1.57e-05	0.000137	CcSEcCtD
Acamprosate—Urticaria—Valproic Acid—epilepsy syndrome	1.56e-05	0.000136	CcSEcCtD
Acamprosate—Rash—Lamotrigine—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Ill-defined disorder—Topiramate—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Dermatitis—Lamotrigine—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Abdominal pain—Valproic Acid—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Body temperature increased—Valproic Acid—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Anorexia—Gabapentin—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Anaemia—Topiramate—epilepsy syndrome	1.55e-05	0.000136	CcSEcCtD
Acamprosate—Headache—Lamotrigine—epilepsy syndrome	1.54e-05	0.000135	CcSEcCtD
Acamprosate—Decreased appetite—Pregabalin—epilepsy syndrome	1.54e-05	0.000135	CcSEcCtD
Acamprosate—Agitation—Topiramate—epilepsy syndrome	1.54e-05	0.000135	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.53e-05	0.000134	CcSEcCtD
Acamprosate—Hypotension—Gabapentin—epilepsy syndrome	1.52e-05	0.000133	CcSEcCtD
Acamprosate—Nausea—Carbamazepine—epilepsy syndrome	1.52e-05	0.000133	CcSEcCtD
Acamprosate—Pain—Pregabalin—epilepsy syndrome	1.51e-05	0.000133	CcSEcCtD
Acamprosate—Constipation—Pregabalin—epilepsy syndrome	1.51e-05	0.000133	CcSEcCtD
Acamprosate—Malaise—Topiramate—epilepsy syndrome	1.51e-05	0.000132	CcSEcCtD
Acamprosate—Vertigo—Topiramate—epilepsy syndrome	1.5e-05	0.000132	CcSEcCtD
Acamprosate—Syncope—Topiramate—epilepsy syndrome	1.5e-05	0.000132	CcSEcCtD
Acamprosate—Leukopenia—Topiramate—epilepsy syndrome	1.5e-05	0.000131	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.48e-05	0.00013	CcSEcCtD
Acamprosate—Palpitations—Topiramate—epilepsy syndrome	1.48e-05	0.00013	CcSEcCtD
Acamprosate—Loss of consciousness—Topiramate—epilepsy syndrome	1.47e-05	0.000129	CcSEcCtD
Acamprosate—Insomnia—Gabapentin—epilepsy syndrome	1.47e-05	0.000129	CcSEcCtD
Acamprosate—Nausea—Lamotrigine—epilepsy syndrome	1.46e-05	0.000128	CcSEcCtD
Acamprosate—Cough—Topiramate—epilepsy syndrome	1.46e-05	0.000128	CcSEcCtD
Acamprosate—Feeling abnormal—Pregabalin—epilepsy syndrome	1.46e-05	0.000128	CcSEcCtD
Acamprosate—Paraesthesia—Gabapentin—epilepsy syndrome	1.46e-05	0.000128	CcSEcCtD
Acamprosate—Convulsion—Topiramate—epilepsy syndrome	1.45e-05	0.000127	CcSEcCtD
Acamprosate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.45e-05	0.000127	CcSEcCtD
Acamprosate—Dyspnoea—Gabapentin—epilepsy syndrome	1.45e-05	0.000127	CcSEcCtD
Acamprosate—Hypertension—Topiramate—epilepsy syndrome	1.45e-05	0.000127	CcSEcCtD
Acamprosate—Somnolence—Gabapentin—epilepsy syndrome	1.44e-05	0.000127	CcSEcCtD
Acamprosate—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.44e-05	0.000127	CcSEcCtD
Acamprosate—Dyspepsia—Gabapentin—epilepsy syndrome	1.43e-05	0.000125	CcSEcCtD
Acamprosate—Chest pain—Topiramate—epilepsy syndrome	1.43e-05	0.000125	CcSEcCtD
Acamprosate—Arthralgia—Topiramate—epilepsy syndrome	1.43e-05	0.000125	CcSEcCtD
Acamprosate—Myalgia—Topiramate—epilepsy syndrome	1.43e-05	0.000125	CcSEcCtD
Acamprosate—Anxiety—Topiramate—epilepsy syndrome	1.42e-05	0.000125	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.42e-05	0.000124	CcSEcCtD
Acamprosate—Decreased appetite—Gabapentin—epilepsy syndrome	1.41e-05	0.000124	CcSEcCtD
Acamprosate—Discomfort—Topiramate—epilepsy syndrome	1.41e-05	0.000123	CcSEcCtD
Acamprosate—Urticaria—Pregabalin—epilepsy syndrome	1.41e-05	0.000123	CcSEcCtD
Acamprosate—Asthenia—Valproic Acid—epilepsy syndrome	1.41e-05	0.000123	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.4e-05	0.000123	CcSEcCtD
Acamprosate—Body temperature increased—Pregabalin—epilepsy syndrome	1.4e-05	0.000123	CcSEcCtD
Acamprosate—Abdominal pain—Pregabalin—epilepsy syndrome	1.4e-05	0.000123	CcSEcCtD
Acamprosate—Dry mouth—Topiramate—epilepsy syndrome	1.39e-05	0.000122	CcSEcCtD
Acamprosate—Constipation—Gabapentin—epilepsy syndrome	1.39e-05	0.000122	CcSEcCtD
Acamprosate—Pain—Gabapentin—epilepsy syndrome	1.39e-05	0.000122	CcSEcCtD
Acamprosate—Pruritus—Valproic Acid—epilepsy syndrome	1.39e-05	0.000122	CcSEcCtD
Acamprosate—Confusional state—Topiramate—epilepsy syndrome	1.38e-05	0.000121	CcSEcCtD
Acamprosate—Infection—Topiramate—epilepsy syndrome	1.36e-05	0.000119	CcSEcCtD
Acamprosate—Shock—Topiramate—epilepsy syndrome	1.34e-05	0.000118	CcSEcCtD
Acamprosate—Diarrhoea—Valproic Acid—epilepsy syndrome	1.34e-05	0.000118	CcSEcCtD
Acamprosate—Feeling abnormal—Gabapentin—epilepsy syndrome	1.34e-05	0.000117	CcSEcCtD
Acamprosate—Thrombocytopenia—Topiramate—epilepsy syndrome	1.34e-05	0.000117	CcSEcCtD
Acamprosate—Tachycardia—Topiramate—epilepsy syndrome	1.33e-05	0.000117	CcSEcCtD
Acamprosate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.33e-05	0.000116	CcSEcCtD
Acamprosate—Skin disorder—Topiramate—epilepsy syndrome	1.33e-05	0.000116	CcSEcCtD
Acamprosate—Hyperhidrosis—Topiramate—epilepsy syndrome	1.32e-05	0.000116	CcSEcCtD
Acamprosate—Hypersensitivity—Pregabalin—epilepsy syndrome	1.3e-05	0.000114	CcSEcCtD
Acamprosate—Anorexia—Topiramate—epilepsy syndrome	1.3e-05	0.000114	CcSEcCtD
Acamprosate—Dizziness—Valproic Acid—epilepsy syndrome	1.3e-05	0.000114	CcSEcCtD
Acamprosate—Urticaria—Gabapentin—epilepsy syndrome	1.29e-05	0.000113	CcSEcCtD
Acamprosate—Abdominal pain—Gabapentin—epilepsy syndrome	1.28e-05	0.000113	CcSEcCtD
Acamprosate—Body temperature increased—Gabapentin—epilepsy syndrome	1.28e-05	0.000113	CcSEcCtD
Acamprosate—Hypotension—Topiramate—epilepsy syndrome	1.28e-05	0.000112	CcSEcCtD
Acamprosate—Asthenia—Pregabalin—epilepsy syndrome	1.27e-05	0.000111	CcSEcCtD
Acamprosate—Pruritus—Pregabalin—epilepsy syndrome	1.25e-05	0.00011	CcSEcCtD
Acamprosate—Vomiting—Valproic Acid—epilepsy syndrome	1.25e-05	0.000109	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.24e-05	0.000109	CcSEcCtD
Acamprosate—Insomnia—Topiramate—epilepsy syndrome	1.24e-05	0.000108	CcSEcCtD
Acamprosate—Rash—Valproic Acid—epilepsy syndrome	1.24e-05	0.000108	CcSEcCtD
Acamprosate—Dermatitis—Valproic Acid—epilepsy syndrome	1.23e-05	0.000108	CcSEcCtD
Acamprosate—Headache—Valproic Acid—epilepsy syndrome	1.23e-05	0.000108	CcSEcCtD
Acamprosate—Paraesthesia—Topiramate—epilepsy syndrome	1.23e-05	0.000108	CcSEcCtD
Acamprosate—Dyspnoea—Topiramate—epilepsy syndrome	1.22e-05	0.000107	CcSEcCtD
Acamprosate—Somnolence—Topiramate—epilepsy syndrome	1.21e-05	0.000107	CcSEcCtD
Acamprosate—Diarrhoea—Pregabalin—epilepsy syndrome	1.21e-05	0.000106	CcSEcCtD
Acamprosate—Dyspepsia—Topiramate—epilepsy syndrome	1.2e-05	0.000105	CcSEcCtD
Acamprosate—Hypersensitivity—Gabapentin—epilepsy syndrome	1.2e-05	0.000105	CcSEcCtD
Acamprosate—Decreased appetite—Topiramate—epilepsy syndrome	1.19e-05	0.000104	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.18e-05	0.000103	CcSEcCtD
Acamprosate—Dizziness—Pregabalin—epilepsy syndrome	1.17e-05	0.000103	CcSEcCtD
Acamprosate—Pain—Topiramate—epilepsy syndrome	1.17e-05	0.000102	CcSEcCtD
Acamprosate—Constipation—Topiramate—epilepsy syndrome	1.17e-05	0.000102	CcSEcCtD
Acamprosate—Asthenia—Gabapentin—epilepsy syndrome	1.17e-05	0.000102	CcSEcCtD
Acamprosate—Nausea—Valproic Acid—epilepsy syndrome	1.16e-05	0.000102	CcSEcCtD
Acamprosate—Pruritus—Gabapentin—epilepsy syndrome	1.15e-05	0.000101	CcSEcCtD
Acamprosate—Vomiting—Pregabalin—epilepsy syndrome	1.13e-05	9.88e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Topiramate—epilepsy syndrome	1.13e-05	9.87e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.12e-05	9.8e-05	CcSEcCtD
Acamprosate—Rash—Pregabalin—epilepsy syndrome	1.12e-05	9.79e-05	CcSEcCtD
Acamprosate—Dermatitis—Pregabalin—epilepsy syndrome	1.12e-05	9.78e-05	CcSEcCtD
Acamprosate—Diarrhoea—Gabapentin—epilepsy syndrome	1.11e-05	9.74e-05	CcSEcCtD
Acamprosate—Headache—Pregabalin—epilepsy syndrome	1.11e-05	9.73e-05	CcSEcCtD
Acamprosate—Urticaria—Topiramate—epilepsy syndrome	1.09e-05	9.52e-05	CcSEcCtD
Acamprosate—Body temperature increased—Topiramate—epilepsy syndrome	1.08e-05	9.47e-05	CcSEcCtD
Acamprosate—Abdominal pain—Topiramate—epilepsy syndrome	1.08e-05	9.47e-05	CcSEcCtD
Acamprosate—Dizziness—Gabapentin—epilepsy syndrome	1.07e-05	9.42e-05	CcSEcCtD
Acamprosate—Nausea—Pregabalin—epilepsy syndrome	1.05e-05	9.23e-05	CcSEcCtD
Acamprosate—Vomiting—Gabapentin—epilepsy syndrome	1.03e-05	9.06e-05	CcSEcCtD
Acamprosate—Rash—Gabapentin—epilepsy syndrome	1.02e-05	8.98e-05	CcSEcCtD
Acamprosate—Dermatitis—Gabapentin—epilepsy syndrome	1.02e-05	8.97e-05	CcSEcCtD
Acamprosate—Headache—Gabapentin—epilepsy syndrome	1.02e-05	8.92e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Topiramate—epilepsy syndrome	1.01e-05	8.83e-05	CcSEcCtD
Acamprosate—Asthenia—Topiramate—epilepsy syndrome	9.8e-06	8.6e-05	CcSEcCtD
Acamprosate—Pruritus—Topiramate—epilepsy syndrome	9.67e-06	8.48e-05	CcSEcCtD
Acamprosate—Nausea—Gabapentin—epilepsy syndrome	9.65e-06	8.46e-05	CcSEcCtD
Acamprosate—Diarrhoea—Topiramate—epilepsy syndrome	9.35e-06	8.2e-05	CcSEcCtD
Acamprosate—Dizziness—Topiramate—epilepsy syndrome	9.04e-06	7.92e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—CDC42—epilepsy syndrome	8.8e-06	0.000104	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	8.77e-06	0.000104	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	8.74e-06	0.000103	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—TSC2—epilepsy syndrome	8.72e-06	0.000103	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MTOR—epilepsy syndrome	8.72e-06	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CHRM2—epilepsy syndrome	8.71e-06	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BDKRB1—epilepsy syndrome	8.71e-06	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CX3CL1—epilepsy syndrome	8.71e-06	0.000103	CbGpPWpGaD
Acamprosate—Vomiting—Topiramate—epilepsy syndrome	8.69e-06	7.62e-05	CcSEcCtD
Acamprosate—Rash—Topiramate—epilepsy syndrome	8.62e-06	7.55e-05	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	8.62e-06	0.000102	CbGpPWpGaD
Acamprosate—Dermatitis—Topiramate—epilepsy syndrome	8.61e-06	7.55e-05	CcSEcCtD
Acamprosate—Headache—Topiramate—epilepsy syndrome	8.56e-06	7.51e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CDC42—epilepsy syndrome	8.51e-06	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GABBR1—epilepsy syndrome	8.48e-06	0.0001	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.41e-06	9.95e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.41e-06	9.95e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.41e-06	9.95e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	8.4e-06	9.93e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BCHE—epilepsy syndrome	8.35e-06	9.88e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.26e-06	9.77e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.26e-06	9.77e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.26e-06	9.77e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8.26e-06	9.77e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AVP—epilepsy syndrome	8.24e-06	9.74e-05	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—PRKCB—epilepsy syndrome	8.24e-06	9.74e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	8.23e-06	9.73e-05	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—epilepsy syndrome	8.22e-06	9.72e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BCHE—epilepsy syndrome	8.2e-06	9.7e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—DLG4—epilepsy syndrome	8.15e-06	9.64e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHRNA4—epilepsy syndrome	8.14e-06	9.62e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRH3—epilepsy syndrome	8.13e-06	9.61e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	8.12e-06	9.6e-05	CbGpPWpGaD
Acamprosate—Nausea—Topiramate—epilepsy syndrome	8.12e-06	7.12e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.1e-06	9.58e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	8.08e-06	9.55e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—FYN—epilepsy syndrome	8.03e-06	9.5e-05	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—epilepsy syndrome	8.02e-06	9.48e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—DLG4—epilepsy syndrome	8.01e-06	9.47e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—OPRM1—epilepsy syndrome	8e-06	9.46e-05	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—JUN—epilepsy syndrome	7.99e-06	9.45e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GRIN2B—epilepsy syndrome	7.97e-06	9.42e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	7.89e-06	9.33e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	7.89e-06	9.33e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PLCB1—epilepsy syndrome	7.88e-06	9.32e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	7.85e-06	9.28e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—FYN—epilepsy syndrome	7.83e-06	9.26e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GRIN2B—epilepsy syndrome	7.83e-06	9.25e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—DLG4—epilepsy syndrome	7.83e-06	9.25e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	7.82e-06	9.25e-05	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—JUN—epilepsy syndrome	7.79e-06	9.21e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	7.76e-06	9.17e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PLCB1—epilepsy syndrome	7.74e-06	9.15e-05	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	7.73e-06	9.14e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	7.72e-06	9.13e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—epilepsy syndrome	7.72e-06	9.12e-05	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	7.71e-06	9.12e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	7.68e-06	9.08e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GRIN2B—epilepsy syndrome	7.65e-06	9.04e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—DLG4—epilepsy syndrome	7.63e-06	9.02e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR3—epilepsy syndrome	7.55e-06	8.93e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.55e-06	8.93e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	7.53e-06	8.9e-05	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	7.49e-06	8.86e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.46e-06	8.82e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	7.39e-06	8.73e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPY—epilepsy syndrome	7.36e-06	8.7e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ATP2A2—epilepsy syndrome	7.36e-06	8.7e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.35e-06	8.69e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—FOS—epilepsy syndrome	7.34e-06	8.68e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.33e-06	8.66e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	7.22e-06	8.54e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	7.22e-06	8.54e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	7.22e-06	8.54e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.22e-06	8.54e-05	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCB—epilepsy syndrome	7.18e-06	8.49e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BCHE—epilepsy syndrome	7.17e-06	8.48e-05	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—SRC—epilepsy syndrome	7.17e-06	8.47e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGT—epilepsy syndrome	7.16e-06	8.47e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.15e-06	8.46e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HSPB1—epilepsy syndrome	7.1e-06	8.4e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CRH—epilepsy syndrome	7.1e-06	8.4e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—OXT—epilepsy syndrome	7.1e-06	8.4e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL2—epilepsy syndrome	7.1e-06	8.4e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL3—epilepsy syndrome	7.1e-06	8.4e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	7.06e-06	8.35e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT3—epilepsy syndrome	7.06e-06	8.35e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.02e-06	8.3e-05	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—epilepsy syndrome	7.01e-06	8.29e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—epilepsy syndrome	7.01e-06	8.28e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCB—epilepsy syndrome	7e-06	8.28e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—DLG4—epilepsy syndrome	7e-06	8.27e-05	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—SRC—epilepsy syndrome	6.99e-06	8.26e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ADAM10—epilepsy syndrome	6.89e-06	8.15e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.88e-06	8.14e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT3—epilepsy syndrome	6.88e-06	8.14e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—epilepsy syndrome	6.86e-06	8.11e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GRIN2B—epilepsy syndrome	6.84e-06	8.09e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PLCB1—epilepsy syndrome	6.77e-06	8e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.76e-06	7.99e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ADAM10—epilepsy syndrome	6.72e-06	7.95e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	6.71e-06	7.94e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.65e-06	7.86e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.65e-06	7.86e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KDR—epilepsy syndrome	6.62e-06	7.83e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.62e-06	7.83e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC1—epilepsy syndrome	6.6e-06	7.81e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTK2B—epilepsy syndrome	6.6e-06	7.81e-05	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	6.55e-06	7.74e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.53e-06	7.72e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.53e-06	7.72e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGT—epilepsy syndrome	6.51e-06	7.69e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—epilepsy syndrome	6.45e-06	7.63e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDC42—epilepsy syndrome	6.44e-06	7.61e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR2—epilepsy syndrome	6.42e-06	7.59e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTRK2—epilepsy syndrome	6.42e-06	7.59e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SST—epilepsy syndrome	6.42e-06	7.59e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	6.4e-06	7.57e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.37e-06	7.54e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DUSP6—epilepsy syndrome	6.37e-06	7.53e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6ST—epilepsy syndrome	6.35e-06	7.51e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.31e-06	7.46e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRA2A—epilepsy syndrome	6.29e-06	7.43e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDC42—epilepsy syndrome	6.28e-06	7.42e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.26e-06	7.4e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLAT—epilepsy syndrome	6.26e-06	7.4e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6ST—epilepsy syndrome	6.19e-06	7.32e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	6.19e-06	7.31e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.14e-06	7.26e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	6.07e-06	7.18e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BDKRB2—epilepsy syndrome	6.04e-06	7.14e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL12—epilepsy syndrome	6.04e-06	7.14e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—epilepsy syndrome	6.03e-06	7.13e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RELA—epilepsy syndrome	6.02e-06	7.11e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCB—epilepsy syndrome	6.01e-06	7.11e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6ST—epilepsy syndrome	5.99e-06	7.08e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUNB—epilepsy syndrome	5.93e-06	7.01e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CNR1—epilepsy syndrome	5.93e-06	7.01e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.93e-06	7.01e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	5.91e-06	6.99e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLCB1—epilepsy syndrome	5.91e-06	6.98e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—epilepsy syndrome	5.9e-06	6.97e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HES1—epilepsy syndrome	5.9e-06	6.97e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.82e-06	6.88e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR7—epilepsy syndrome	5.78e-06	6.84e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HES1—epilepsy syndrome	5.75e-06	6.8e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FYN—epilepsy syndrome	5.73e-06	6.78e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.71e-06	6.75e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.71e-06	6.75e-05	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.71e-06	6.75e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MEF2C—epilepsy syndrome	5.7e-06	6.74e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HBEGF—epilepsy syndrome	5.61e-06	6.64e-05	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	5.61e-06	6.63e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FYN—epilepsy syndrome	5.59e-06	6.61e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MEF2C—epilepsy syndrome	5.56e-06	6.57e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT3—epilepsy syndrome	5.51e-06	6.52e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—epilepsy syndrome	5.48e-06	6.47e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.47e-06	6.47e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—epilepsy syndrome	5.43e-06	6.42e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.42e-06	6.41e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADAM10—epilepsy syndrome	5.38e-06	6.36e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—epilepsy syndrome	5.36e-06	6.34e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.32e-06	6.29e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	5.31e-06	6.28e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.28e-06	6.25e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—epilepsy syndrome	5.27e-06	6.23e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.19e-06	6.13e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—S100B—epilepsy syndrome	5.09e-06	6.02e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.09e-06	6.01e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS3—epilepsy syndrome	5.04e-06	5.96e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDC42—epilepsy syndrome	5.03e-06	5.94e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—epilepsy syndrome	4.87e-06	5.76e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCB—epilepsy syndrome	4.74e-06	5.6e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—epilepsy syndrome	4.73e-06	5.59e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—epilepsy syndrome	4.73e-06	5.59e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCB—epilepsy syndrome	4.65e-06	5.5e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.65e-06	5.5e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—epilepsy syndrome	4.61e-06	5.45e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HES1—epilepsy syndrome	4.6e-06	5.44e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.53e-06	5.36e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6ST—epilepsy syndrome	4.53e-06	5.36e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.49e-06	5.31e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FYN—epilepsy syndrome	4.48e-06	5.29e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H2AFX—epilepsy syndrome	4.46e-06	5.27e-05	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—epilepsy syndrome	4.45e-06	5.26e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MEF2C—epilepsy syndrome	4.45e-06	5.26e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6ST—epilepsy syndrome	4.42e-06	5.22e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.41e-06	5.21e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	4.38e-06	5.18e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	4.37e-06	5.16e-05	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—epilepsy syndrome	4.34e-06	5.13e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—YWHAZ—epilepsy syndrome	4.3e-06	5.09e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.28e-06	5.07e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGF—epilepsy syndrome	4.25e-06	5.03e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	4.24e-06	5.02e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.21e-06	4.97e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—epilepsy syndrome	4.14e-06	4.89e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCB—epilepsy syndrome	4.07e-06	4.81e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—epilepsy syndrome	4.06e-06	4.8e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—epilepsy syndrome	4.05e-06	4.79e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—epilepsy syndrome	3.96e-06	4.68e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.85e-06	4.56e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC2—epilepsy syndrome	3.85e-06	4.55e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—epilepsy syndrome	3.84e-06	4.54e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—epilepsy syndrome	3.77e-06	4.45e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—epilepsy syndrome	3.75e-06	4.43e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	3.71e-06	4.38e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—epilepsy syndrome	3.69e-06	4.36e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.68e-06	4.35e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—epilepsy syndrome	3.66e-06	4.33e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—SRC—epilepsy syndrome	3.65e-06	4.32e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—epilepsy syndrome	3.65e-06	4.31e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—epilepsy syndrome	3.57e-06	4.22e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—epilepsy syndrome	3.56e-06	4.2e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCB—epilepsy syndrome	3.55e-06	4.2e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6ST—epilepsy syndrome	3.54e-06	4.18e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.52e-06	4.17e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.49e-06	4.13e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.46e-06	4.09e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.43e-06	4.06e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—epilepsy syndrome	3.4e-06	4.02e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.38e-06	4e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.32e-06	3.93e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RELA—epilepsy syndrome	3.32e-06	3.92e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—epilepsy syndrome	3.23e-06	3.82e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	3.18e-06	3.76e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.17e-06	3.74e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.03e-06	3.58e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3e-06	3.54e-05	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—epilepsy syndrome	2.94e-06	3.47e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.9e-06	3.43e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—epilepsy syndrome	2.9e-06	3.43e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF2—epilepsy syndrome	2.86e-06	3.38e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—epilepsy syndrome	2.83e-06	3.34e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—epilepsy syndrome	2.67e-06	3.16e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—epilepsy syndrome	2.66e-06	3.14e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SRC—epilepsy syndrome	2.61e-06	3.08e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.6e-06	3.08e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—epilepsy syndrome	2.6e-06	3.08e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—epilepsy syndrome	2.54e-06	3e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.42e-06	2.86e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.4e-06	2.83e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—epilepsy syndrome	2.33e-06	2.75e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.26e-06	2.68e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—epilepsy syndrome	2.23e-06	2.64e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.2e-06	2.6e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—epilepsy syndrome	2.17e-06	2.57e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.12e-06	2.5e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SRC—epilepsy syndrome	2.09e-06	2.47e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.08e-06	2.46e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.03e-06	2.4e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.82e-06	2.15e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—epilepsy syndrome	1.66e-06	1.96e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—epilepsy syndrome	1.62e-06	1.91e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.3e-06	1.53e-05	CbGpPWpGaD
